MoonLake Immunotherapeutics (MLTX) Cash from Investing Activities (QoQ) (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) Cash from Investing Activities (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | MoonLake Immunotherapeutics | 1.41 Bn | 1.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.33% |
| Dec 31, 2025 | -133.83% |
| Sep 30, 2025 | 0.17% |
| Jun 30, 2025 | 56.91% |
| Mar 31, 2025 | 138.18% |
| Dec 31, 2024 | -352.79% |
| Sep 30, 2024 | 166.42% |
| Jun 30, 2024 | -204.62% |
| Mar 31, 2024 | -124.65% |
| Dec 31, 2023 | 167.02% |
| Sep 30, 2023 | -1,475.63% |
| Jun 30, 2023 | -35.49% |
| Mar 31, 2023 | 98.44% |
| Dec 31, 2022 | 123.45% |
| Sep 30, 2022 | -2,111,301,200.00% |
| Jun 30, 2022 | 100.01% |
| Mar 31, 2022 | 68.43% |
| Dec 31, 2021 | -335.32% |